|
Hot Stocks
| ShowHide Related Items >><< - 09:47 Today
- Turkcell falls -4.5%
- 03/09/23
- Turkcell trading resumes
- 03/09/23
- Turkcell sees TRY 1.5B revenue impact from earthquakes
- 03/09/23
- Turkcell trading halted, news pending
- 01/31/23 JPMorgan
- Turkcell price target raised to TRY 43 from TRY 26.05 at JPMorgan
- 07/15/22 JPMorgan
- Turkcell price target raised to TRY 22.55 from TRY 22.10 at JPMorgan
- 03/09/23
- Turkcell sees 2023 revenue growth 55%-57%, EBITDA around TRY 34B
- 03/09/23
- Turkcell reports Q4 revenue TRY16.04B vs. TRY10.19B last year
|
|
Hot Stocks
| ShowHide Related Items >><< - 03/13/23
- Altus Power confirms no exposure to SVB, Signature Bank or First Republic Bank
- 02/10/23
- Altus Power, CBRE and Blackstone advance Community Solar Partnership Program
- 02/06/23
- Altus Power appoints Sophia Lee as Chief Sustainability Officer
- 12/27/22
- Altus Power to acquire 220 MW of construction solar assets for $293M
- 01/10/23 Morgan Stanley
- Altus Power upgraded to Overweight from Equal Weight at Morgan Stanley
- 01/04/23 Evercore ISI
- Evercore starts 'differentiated' C&I solar developer Altus Power at Outperform
- 01/04/23 Evercore ISI
- Altus Power initiated with an Outperform at Evercore ISI
- 12/13/22 Citi
- Altus Power price target lowered to $10 from $11 at Citi
|
|
Hot Stocks
|
McCormick is up 12.9%, or… ShowHide Related Items >><< - 12/05/22
- McCormick names Sarah Piper as Chief Human Relations Officer
- 11/29/22
- McCormick raises quarterly dividend to 39c from 37c per share
- 11/01/22
- McCormick Chief Human Relations Officer Lisa Manzone retiring
- 03/21/23 Credit Suisse
- McCormick price target lowered to $72 from $75 at Credit Suisse
- 03/20/23 Deutsche Bank
- McCormick price target lowered to $69 from $74 at Deutsche Bank
- 03/10/23 UBS
- McCormick initiated with a Sell at UBS
- 01/27/23 Deutsche Bank
- McCormick price target lowered to $74 from $83 at Deutsche Bank
- 06:36 Today
- McCormick sees 2023 adjusted EPS $2.56-$2.61, consensus $2.57
- 06:33 Today
- McCormick reports Q1 adjusted EPS 59c, consensus 51c
- 01/26/23
- McCormick sees FY23 EPS $2.56-$2.61, consensus $2.90
- 01/26/23
- McCormick reports Q4 adjusted EPS 73c, consensus 86c
- 08:51 Today
- Fly Intel: Pre-market Movers
- 03/10/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 01/27/23
- What You Missed On Wall Street On Friday
- 01/27/23
- What You Missed On Wall Street This Morning
- 09:55 Today
- Early notable gainers among liquid option names on March 28th
|
|
Hot Stocks
|
PVH Corp. is up 17.8%, or… ShowHide Related Items >><< - $86.67 /
+13.08 (+17.77%) - 09:47 Today
- PVH Corp. rises 13.7%
- 03/27/23
- PVH Corp. jumps 10% to $80.80 after Q4 results, FY23 guidance beat estimates
- 03/08/23
- PVH Corp. names Amber McCann Chief Communications Office
- 12/01/22
- PVH Corp. rises 10.2%
- $86.67 /
+13.08 (+17.77%) - 06:22 Today Credit Suisse
- PVH Corp. price target raised to $93 from $87 at Credit Suisse
- 03/21/23 UBS
- PVH Corp. price target lowered to $92 from $100 at UBS
- 03/20/23 Goldman Sachs
- PVH Corp. price target raised to $74 from $67 at Goldman Sachs
- 02/15/23 Wells Fargo
- PVH Corp. price target raised to $110 from $85 at Wells Fargo
- $86.67 /
+13.08 (+17.77%) - 03/27/23
- PVH Corp. sees FY23 EPS roughly $8.97, consensus $8.92
- 03/27/23
- PVH Corp. sees Q1 EPS roughly $1.90, consensus $1.88
- 03/27/23
- PVH Corp. reports Q4 adjusted EPS $2.38, consensus $1.67
- 11/30/22
- PVH Corp. raises FY22 EPS view to $8.25 from $8, consensus $7.89
- $86.67 /
+13.08 (+17.77%) - 08:51 Today
- Fly Intel: Pre-market Movers
- 03/27/23
- Fly Intel: After-Hours Movers
- 12/01/22
- What You Missed On Wall Street On Thursday
- 12/01/22
- What You Missed On Wall Street This Morning
- $86.67 /
+13.08 (+17.77%) - 03/27/23
- PVH Corp. options imply 5.1% move in share price post-earnings
|
|
Hot Stocks
|
Oscar Health is up 53.8%,… ShowHide Related Items >><< - 09:47 Today
- Oscar Health rises 40.8%
- 07:12 Today
- Oscar Health announces appointment of Bertolini as CEO
- 03/15/23
- Oscar Health announces Dr. Sean Martin, MD appointed CMO
- 03/06/23
- Oscar Health announces renewed agreement with CVS Caremark
- 02/14/23 Cowen
- Oscar Health price target raised to $6.00 from $3.00 at Cowen
- 11/16/22 Wells Fargo
- Wells Fargo upgrades Oscar Health to Overweight on 'too favorable' risk/reward
- 11/15/22 Wells Fargo
- Oscar Health upgraded to Overweight from Equal Weight at Wells Fargo
- 11/14/22 Morgan Stanley
- Oscar Health downgraded to Equal Weight from Overweight at Morgan Stanley
- 02/09/23
- Oscar Health sees FY23 adjusted EBITDA ($175M)-($75M)
- 02/09/23
- Oscar Health reports Q4 EPS ($1.05), consensus ($1.16)
- 11/08/22
- Oscar sees FY22 adjusted EBITDA modesty above high end of ($480M)-($380M) range
- 11/08/22
- Oscar Health reports Q3 EPS (91c), consensus (73c)
- 11/16/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
|
|
On The Fly
|
Want to get stock-moving… ShowHide Related Items >><< - 03/23/23
- BlackBerry, Adobe partner on secure forms solution for mobile
- 03/22/23
- Adobe, Prada Group announce partnership
- 03/22/23
- General Motors selects Adobe Experience Cloud
- 03/21/23
- Nvidia, Adobe to co-develop new generation of advanced generative AI models
- 03/24/23
- FactSet appoints Elisha Wiesel to board of directors
- 03/23/23
- FactSet expects to resume share repurchase program in Q3, Q4
- 01/26/23
- BMO Wealth Management selects FactSet as market data provider
- 01/11/23
- FactSet, Coin Metrics collaborate for digital asset data, analytics
- 03/12/23
- Fly Intel: Top five weekend stock stories
- 03/01/23
- User reports indicate problems at Paramount+, Downdetector says
- 02/16/23
- Paramount expects to raise Paramount+ price $2.00 on premium tier
- 02/16/23
- Paramount expects slower recovery in international ad market
- 03/27/23
- Carnival CEO says 'well booked for the remainder of the year at higher prices'
- 03/27/23
- Carnival ends Q1 with $8.1B of liquidity
- 01/27/23
- Salesforce appoints three new independent directors to board
- 01/18/23
- Carnival expands next-generation wi-fi connectivity with SpaceX's Starlink
- 02/02/23
- Managed care stocks pressured after CMS' preliminary Medicare Advantage rates
- 01/25/23
- Elevance Health raises share repurchase program by $5B
- 01/25/23
- Elevance Health raises quarterly dividend 16% to $1.48 per share
- 01/23/23
- Elevance Health to acquire Blue Cross and Blue Shield of Louisiana
- 03/14/23
- Senate Democrats urge Walmart, Kroger, others to sell mifepristone
- 03/02/23
- Walmart to open 28 new Walmart Health center locations in 2024
- 02/28/23
- Citi, Walmart introduce the Bridge built by Citi platform to Walmart suppliers
- 02/28/23
- Walmart, CareSource enter agreement to address health disparities
- 03/16/23
- Fox Corp. announces 'Fox Future' Studio Lot Project
- 02/14/23
- Fox Sports says Super Bowl LVII was most-streamed Super Bowl in history
- 02/08/23
- Fox Corp. announces $1B accelerated share repurchase plan
- 02/08/23
- Fox Corp. announces incremental $3B stock repurchase authorization
- 12/14/22
- Cerence enters partnerships with iHeartMedia, Radioline
- 11/28/22
- California AG announces settlements against Google, iHeartMedia over radio ads
- 11/28/22
- FTC, state AGs announce settlement with Google and iHeartMedia over Pixel 4 ads
- 03/08/23
- Marathon Petroleum acquires 49.9% stake in emerging LF Bioenergy
- 02/14/23
- Elliott buys NiSource, cuts Aerojet in Q4
- 01/31/23
- Marathon Petroleum sees FY23 capital spending $1.3B
- 01/24/23
- Marathon Petroleum trading resumes
- 02/27/23
- Nutrien announces TSX approval for renewed share repurchase program
- 02/15/23
- Nutrien CEO expects 'global supply issues to persist' in 2023
- 02/15/23
- Nutrien raises quarterly dividend by 10% to 53c per share
- 03/09/23
- Ulta Beauty sees operating margin at 14%-15% over next few years
- 02/05/23
- Fly Intel: Top five weekend stock stories
- 12/05/22
- Ulta Beauty CEO: Consumer is loving what we are offering
- 12/01/22
- Ulta Beauty reports SSS up 14.6% y/y
- $822.48 /
+2.915 (+0.36%) - 08:09 Today
- Immuneering appoints Harold Brakewood as CBO
- 07:37 Today
- Regeneron Pharmaceuticals, Sonoma Biotherapeutics announce collaboration
- 03/23/23
- Regeneron, Sanofi report Dupixent trial meets primary and secondary endpoints
- 03/22/23
- Regeneron announces FDA approval of Evkeeza for young children
- 03/16/23
- Blink Charging enters contract with USPS for EV charging stations
- 03/15/23
- Blink Charging 'delighted' by DOT's new charging infrastructure program
- 03/15/23
- Blink Charging unveils redesigned mobile EV charger
- 02/10/23
- Blink Charging partners with Hertz for EV charging during Big Game
- 02/08/23
- Astria Therapeutics initiates ALPHA-STAR trial
- 12/15/22
- Astria Therapeutics reports positive Phase 1a results of STAR-0215 in HAE
FHTX Foghorn Therapeutics - 03/09/23
- Foghorn Therapeutics expects cash to fund operations into 2H25
- 01/09/23
- Foghorn Therapeutics sees cash runway into 2H25
- 01/09/23
- Foghorn Therapeutics announces strategic objectives for 2023
- 11/08/22
- Foghorn Therapeutics sees cash runway into 2025
- 08:55 Today Erste Group
- Adobe upgraded to Buy from Hold at Erste Group
- 03/24/23 DA Davidson
- DA Davidson sees generative AI as catalyst for connecting Adobe applications
- 03/22/23 RBC Capital
- Adobe price target raised to $415 from $395 at RBC Capital
- 03/17/23 Credit Suisse
- Adobe price target raised to $350 from $325 at Credit Suisse
- 08:44 Today Redburn
- FactSet upgraded to Neutral at Redburn following underperformance
- 06:58 Today Redburn
- FactSet upgraded to Neutral from Sell at Redburn
- 03/24/23 Deutsche Bank
- FactSet price target lowered to $454 from $477 at Deutsche Bank
- 03/24/23 Stifel
- FactSet price target lowered to $408 from $415 at Stifel
- 06:10 Today BofA
- Paramount upgraded to Buy from Neutral at BofA
- 01/31/23 Macquarie
- Paramount downgraded to Underperform at Macquarie on high ad exposure
- 01/31/23 Macquarie
- Paramount downgraded to Underperform from Neutral at Macquarie
- 01/12/23 Guggenheim
- Paramount price target raised to $22 from $20 at Guggenheim
- 05:19 Today Barclays
- Carnival price target raised to $13 from $12 at Barclays
- 05:15 Today Wells Fargo
- Carnival upgraded to Equal Weight from Underweight at Wells Fargo
- 03/27/23 Credit Suisse
- Carnival price target raised to $18 from $16 at Credit Suisse
- 03/22/23 Stifel
- Carnival selloff creates buying opportunity ahead of guidance, says Stifel
- 06:39 Today RBC Capital
- RBC upgrades Elevance Health on building Carelon momentum
- 06:29 Today RBC Capital
- Elevance Health upgraded to Outperform from Sector Perform at RBC Capital
- 03/24/23 Truist
- Elevance Health price target lowered to $580 from $610 at Truist
- 03/21/23 Wells Fargo
- Elevance Health price target lowered to $597 from $609 at Wells Fargo
- 09:14 Today Morgan Stanley
- Morgan Stanley adjusts 'Fresh Money Buy List' to position more defensively
- 09:00 Today Erste Group
- Walmart downgraded to Hold from Buy at Erste Group
- 03/24/23 Needham
- Symbotic price target raised to $25 from $18 at Needham
- 03/17/23 Gordon Haskett
- Gordon Haskett downgrades Dollar General with 'more questions than answers'
- 06:23 Today BofA
- Fox downgraded to Neutral on lack of catalysts at BofA
- 06:12 Today BofA
- Fox Corp. downgraded to Neutral from Buy at BofA
- 02/09/23 Deutsche Bank
- Deutsche Bank keeps Buy on Fox Corp., raises price target to $40
- 02/09/23 Morgan Stanley
- Fox Corp. price target raised to $39 from $37 at Morgan Stanley
- 06:10 Today BofA
- iHeartMedia downgraded to Underperform from Neutral at BofA
- 03/01/23 Barrington
- iHeartMedia downgraded at Barrington amid soft advertising environment
- 03/01/23 Barrington
- iHeartMedia downgraded to Market Perform from Outperform at Barrington
- 03/01/23 B. Riley
- iHeartMedia price target lowered to $16 from $22 at B. Riley
- 04:48 Today JPMorgan
- Marathon Petroleum downgraded to Neutral from Overweight at JPMorgan
- 03/10/23 Mizuho
- Marathon Petroleum upgraded to Buy from Neutral at Mizuho
- 03/08/23 UBS
- UBS starts eight independent refiners with three Buys
- 03/08/23 UBS
- UBS starts 'cash machine' Marathon Petroleum with a Buy
- 08:59 Today Erste Group
- Nutrien downgraded to Hold from Buy at Erste Group
- 02/21/23 HSBC
- Nutrien price target lowered to $81 from $83 at HSBC
- 02/08/23 TD Securities
- Nutrien downgraded to Hold from Buy at TD Securities
- 02/08/23 TD Securities
- Nutrien downgraded to Hold from Buy at TD Securities
- 07:29 Today Canaccord
- Canaccord starts Ulta Beauty with a Buy, sees continued share gains
- 05:42 Today Canaccord
- Ulta Beauty initiated with a Buy at Canaccord
- 03/23/23 Piper Sandler
- Ulta Beauty price target raised to $615 from $610 at Piper Sandler
- 03/13/23 Morgan Stanley
- Ulta Beauty price target raised to $535 from $510 at Morgan Stanley
- $822.48 /
+2.915 (+0.36%) - 09:02 Today Erste Group
- Regeneron resumed with a Buy at Erste Group
- 03/27/23 SVB Securities
- SVB Securities upgrades Regeneron to Outperform, sees positive drivers ahead
- 03/27/23 SVB Securities
- Regeneron upgraded to Outperform from Market Perform at SVB Securities
- 03/24/23 BMO Capital
- Regeneron price target raised to $1,040 from $1,025 at BMO Capital
- 04:57 Today Barclays
- Blink Charging initiated with an Equal Weight at Barclays
- 03/02/23 Roth MKM
- Blink Charging price target lowered to $25 from $45 at Roth MKM
- 03/02/23 Needham
- Blink Charging reinstated with a Hold at Needham
- 03/01/23 Roth MKM
- Blink Charging price target lowered to $25 from $45 at Roth MKM
- 06:07 Today Evercore ISI
- Astria Therapeutics initiated with an Outperform at Evercore ISI
- 12/19/22 H.C. Wainwright
- Astria Therapeutics price target raised to $20 from $13 at H.C. Wainwright
- 10/05/22 H.C. Wainwright
- H.C. Wainwright has more confidence in Astria opportunity after KalVista news
FHTX Foghorn Therapeutics - 06:04 Today BofA
- Foghorn Therapeutics initiated with a Buy at BofA
- 01/05/23 BMO Capital
- Foghorn Therapeutics initiated with an Outperform at BMO Capital
- 11/30/22 Wedbush
- Foghorn Therapeutics removed from Best Ideas List at Wedbush
- 08/23/22 Morgan Stanley
- Morgan Stanley downgrades Foghorn on uncertainty from clinical hold
- 03/15/23
- Adobe raises FY23 adjusted EPS view to $15.30-$15.60 from $15.15-$15.45
- 03/15/23
- Adobe sees Q2 adjusted EPS $3.75-$3.80, consensus $3.76
- 03/15/23
- Adobe reports Q1 adjusted EPS $3.80, consensus $3.68
- 12/15/22
- Adobe backs FY23 adjusted EPS view $15.15-$15.45, consensus $15.25
- 03/23/23
- FactSet sees 2023 adjusted EPS $14.50-$14.90, consensus $14.89
- 03/23/23
- FactSet reports Q2 adjusted EPS $3.80, consensus $3.69
- 12/20/22
- FactSet reaffirms 2023 adjusted EPS view $14.50-$14.90, consensus $14.79
- 12/20/22
- FactSet reports Q1 adjusted EPS $3.99, consensus $3.61
- 02/16/23
- Paramount sees Q1 OIBDA similar to Q4; expects a Q1 EPS loss
- 02/16/23
- Paramount reports Q4 adjusted EPS 8c, consensus 24c
- 02/15/23
- Notable companies reporting before tomorrow's open
- 02/15/23
- Notable companies reporting before tomorrow's open
- 03/27/23
- Carnival sees Q2 adjusted EBITDA $600M-$700M
- 03/27/23
- Carnival sees FY23 adjusted EBITDA $3.9B-$4.1B
- 03/27/23
- Carnival sees FY23 adjusted EPS (44c)-(28c), consensus (8c)
- 03/27/23
- Carnival sees Q2 adjusted EPS (42c)-(34c), consensus (28c)
- 01/25/23
- Elevance Health sees FY23 adjusted EPS 'greater than' $32.60, consensus $32.69
- 01/25/23
- Elevance Health reports Q4 adjusted EPS $5.23, consensus $5.19
- 10/19/22
- Elevance Health raises FY22 adjusted EPS view to greater than $28.95 per share
- 10/19/22
- Elevance Health reports Q3 adjusted EPS $7.53, consensus $7.15
- 02/21/23
- Walmart sees FY24 adjusted EPS $5.90-$6.05, consensus $6.50
- 02/21/23
- Walmart sees Q1 adjusted EPS $1.25-$1.30, consensus $1.36
- 02/21/23
- Walmart reports Q4 adjusted EPS $1.71, consensus $1.51
- 11/15/22
- Walmart raises FY23 adjusted EPS view to down 5%-6% from down 9%-11%
- 02/08/23
- Fox Corp. reports Q2 adjusted EPS 48c, consensus 48c
- 02/07/23
- Notable companies reporting before tomorrow's open
- 02/07/23
- Notable companies reporting before tomorrow's open
- 11/01/22
- Fox Corp. reports Q1 adjusted EPS $1.21, consensus $1.14
- 02/28/23
- iHeartMedia sees Q1 revenue down mid-single digits
- 02/28/23
- iHeartMedia reports Q4 adjusted EBITDA $316M, up 7% from last year
- 11/03/22
- iHeartMedia sees Q4 revenue growth 2%-6%, consensus $1.14B
- 11/03/22
- iHeartMedia reports Q3 revenue $989M, consensus $975.44M
- 01/31/23
- Marathon Petroleum reports Q4 adjusted EPS $6.65, consensus $5.67
- 11/01/22
- Marathon Petroleum reports Q3 EPS $7.81, consensus $6.95
- 02/15/23
- Nutrien sees FY23 adjusted EPS $8.45-$10.65, consensus $11.49
- 02/15/23
- Nutrien reports Q4 adjusted EPS $2.02, consensus $2.62
- 11/02/22
- Nutrien reports Q3 EPS $2.51, consensus $3.97
- 03/09/23
- Ulta Beauty guides initial FY23 EPS $24.70-$25.40, consensus $24.25
- 03/09/23
- Ulta Beauty reports Q4 EPS $6.68, consensus $5.66
- 03/09/23
- Notable companies reporting after market close
- 12/01/22
- Ulta Beauty raises FY22 EPS view to $22.60-$22.90 from $20.70-$21.20
- $822.48 /
+2.915 (+0.36%) - 02/03/23
- Regeneron reports Q4 adjusted EPS $12.56, consensus $10.03
- 02/02/23
- Notable companies reporting before tomorrow's open
- 02/02/23
- Notable companies reporting before tomorrow's open
- 01/09/23
- Regeneron sees about $1.5B in Q4 U.S. net product sales of Eylea
- 02/28/23
- Blink Charging sees FY23 revenue $100M-$110M, consensus $91.57M
- 02/28/23
- Blink Charging reports Q4 adjusted EPS (41c), consensus (48c)
- 02/06/23
- Blink Charging sees Q4 revenue $21M-$23M, consensus $18.7M
- 11/08/22
- Blink Charging reports Q3 adjusted EPS (47c), consensus (51c)
- 03/22/23
- Astria Therapeutics reports Q4 EPS (72c), consensus (71c)
- 11/10/22
- Astria Therapeutics reports Q3 EPS (87c), consensus (92c)
FHTX Foghorn Therapeutics - 03/09/23
- Foghorn Therapeutics reports 2022 EPS ($2.62), consensus ($2.51)
- 11/08/22
- Foghorn Therapeutics reports Q3 EPS (62c), consensus (62c)
|
|
Options
| ShowHide Related Items >><< - 12/05/22
- McCormick names Sarah Piper as Chief Human Relations Officer
- 11/29/22
- McCormick raises quarterly dividend to 39c from 37c per share
- 11/01/22
- McCormick Chief Human Relations Officer Lisa Manzone retiring
- 03/12/23
- Fly Intel: Top five weekend stock stories
- 03/01/23
- User reports indicate problems at Paramount+, Downdetector says
- 02/16/23
- Paramount expects to raise Paramount+ price $2.00 on premium tier
- 02/16/23
- Paramount expects slower recovery in international ad market
- 02/09/23
- Ralph Lauren CEO: Macro environment 'choppy,' consumer 'resilient'
- 01/25/23
- Ralph Lauren CEO sells $2.31M in common stock
- 01/19/23
- Ralph Lauren CEO sells $2.22M in common stock
- 11/10/22
- Ralph Lauren sees gross margin expansion in 2H
- 03/27/23
- Carnival CEO says 'well booked for the remainder of the year at higher prices'
- 03/27/23
- Carnival ends Q1 with $8.1B of liquidity
- 01/27/23
- Salesforce appoints three new independent directors to board
- 01/18/23
- Carnival expands next-generation wi-fi connectivity with SpaceX's Starlink
- 03/06/23
- Bath & Body Works announces appointment of Kuhn to board of directors
- 02/27/23
- Bath & Body Works calls Third Point's potential proxy contest 'misguided'
- 02/23/23
- Bath & Body Works taking enterprise-wide effort to reduce expenses
- 02/23/23
- Bath & Body Works responds to Third Point intent to nominate board candidates
- 03/21/23 Credit Suisse
- McCormick price target lowered to $72 from $75 at Credit Suisse
- 03/20/23 Deutsche Bank
- McCormick price target lowered to $69 from $74 at Deutsche Bank
- 03/10/23 UBS
- McCormick initiated with a Sell at UBS
- 01/27/23 Deutsche Bank
- McCormick price target lowered to $74 from $83 at Deutsche Bank
- 06:10 Today BofA
- Paramount upgraded to Buy from Neutral at BofA
- 01/31/23 Macquarie
- Paramount downgraded to Underperform at Macquarie on high ad exposure
- 01/31/23 Macquarie
- Paramount downgraded to Underperform from Neutral at Macquarie
- 01/12/23 Guggenheim
- Paramount price target raised to $22 from $20 at Guggenheim
- 02/13/23 BofA
- Ralph Lauren upgraded to Buy from Neutral at BofA
- 02/10/23 Deutsche Bank
- Ralph Lauren price target raised to $119 from $114 at Deutsche Bank
- 02/10/23 Cowen
- Ralph Lauren price target raised to $151 from $148 at Cowen
- 02/10/23 Credit Suisse
- Ralph Lauren price target raised to $135 from $115 at Credit Suisse
- 05:19 Today Barclays
- Carnival price target raised to $13 from $12 at Barclays
- 05:15 Today Wells Fargo
- Carnival upgraded to Equal Weight from Underweight at Wells Fargo
- 03/27/23 Credit Suisse
- Carnival price target raised to $18 from $16 at Credit Suisse
- 03/22/23 Stifel
- Carnival selloff creates buying opportunity ahead of guidance, says Stifel
- 03/23/23 Piper Sandler
- Bath & Body Works price target lowered to $48 from $52 at Piper Sandler
- 03/17/23 Argus
- Bath & Body Works cut to Hold at Argus on online competition, slowing sales
- 03/17/23 Argus
- Bath & Body Works downgraded to Hold from Buy at Argus
- 02/24/23 Deutsche Bank
- Bath & Body Works price target lowered to $47 from $55 at Deutsche Bank
- 06:36 Today
- McCormick sees 2023 adjusted EPS $2.56-$2.61, consensus $2.57
- 06:33 Today
- McCormick reports Q1 adjusted EPS 59c, consensus 51c
- 01/26/23
- McCormick sees FY23 EPS $2.56-$2.61, consensus $2.90
- 01/26/23
- McCormick reports Q4 adjusted EPS 73c, consensus 86c
- 02/16/23
- Paramount sees Q1 OIBDA similar to Q4; expects a Q1 EPS loss
- 02/16/23
- Paramount reports Q4 adjusted EPS 8c, consensus 24c
- 02/15/23
- Notable companies reporting before tomorrow's open
- 02/15/23
- Notable companies reporting before tomorrow's open
- 02/09/23
- Ralph Lauren backs FY23 revenue view up 13.5%-14%, consensus $6.28B
- 02/09/23
- Ralph Lauren sees Q4 revenue up mid- to high-single digits, consensus $1.45B
- 02/09/23
- Ralph Lauren reports Q3 EPS $3.20, consensus $2.92
- 02/08/23
- Notable companies reporting before tomorrow's open
- 03/27/23
- Carnival sees Q2 adjusted EBITDA $600M-$700M
- 03/27/23
- Carnival sees FY23 adjusted EBITDA $3.9B-$4.1B
- 03/27/23
- Carnival sees FY23 adjusted EPS (44c)-(28c), consensus (8c)
- 03/27/23
- Carnival sees Q2 adjusted EPS (42c)-(34c), consensus (28c)
- 02/23/23
- Bath & Body Works sees FY23 cont ops EPS $2.50-$3.00, consensus $3.16
- 02/23/23
- Bath & Body Works sees Q1 cont ops EPS 17c-27c, consensus 44c
- 02/23/23
- Bath & Body Works reports Q4 cont ops EPS $1.86, consensus $1.62
- 02/22/23
- Notable companies reporting before tomorrow's open
|
|
General news
| ShowHide Related Items >><< - 03/22/23
- Senators Scott, Warren unveil bipartisan Fed oversight legislation
- 03/01/23
- Einhorn says investors should be 'bearish on stocks and bullish on inflation'
- 03/08/23
- Biden to propose 25% billionaire tax, Bloomberg says
- 03/08/23
- Biden to propose 25% billionaire tax, Bloomberg says
- 03/07/23
- Powell tells Congress data from January partly reversed softening trends
- 01/30/23
- Fed likely to raise funds rate benchmark by quarter percentage point, WSJ says
- 03/22/23
- What You Missed On Wall Street On Wednesday
- 03/21/23
- What You Missed On Wall Street On Tuesday
- 03/21/23
- What You Missed On Wall Street This Morning
- 03/08/23
- What You Missed On Wall Street On Wednesday
- 03/22/23
- Fed says 'additional policy firming may be appropriate'
|
|
General news
| ShowHide Related Items >><< - 03/22/23
- Senators Scott, Warren unveil bipartisan Fed oversight legislation
- 03/01/23
- Einhorn says investors should be 'bearish on stocks and bullish on inflation'
- 03/08/23
- Biden to propose 25% billionaire tax, Bloomberg says
- 03/08/23
- Biden to propose 25% billionaire tax, Bloomberg says
- 03/07/23
- Powell tells Congress data from January partly reversed softening trends
- 01/30/23
- Fed likely to raise funds rate benchmark by quarter percentage point, WSJ says
- 03/22/23
- What You Missed On Wall Street On Wednesday
- 03/21/23
- What You Missed On Wall Street On Tuesday
- 03/21/23
- What You Missed On Wall Street This Morning
- 03/08/23
- What You Missed On Wall Street On Wednesday
- 03/22/23
- Fed says 'additional policy firming may be appropriate'
|
|
General news
| ShowHide Related Items >><< - 03/22/23
- Senators Scott, Warren unveil bipartisan Fed oversight legislation
- 03/01/23
- Einhorn says investors should be 'bearish on stocks and bullish on inflation'
- 03/08/23
- Biden to propose 25% billionaire tax, Bloomberg says
- 03/08/23
- Biden to propose 25% billionaire tax, Bloomberg says
- 03/07/23
- Powell tells Congress data from January partly reversed softening trends
- 01/30/23
- Fed likely to raise funds rate benchmark by quarter percentage point, WSJ says
- 03/22/23
- What You Missed On Wall Street On Wednesday
- 03/21/23
- What You Missed On Wall Street On Tuesday
- 03/21/23
- What You Missed On Wall Street This Morning
- 03/08/23
- What You Missed On Wall Street On Wednesday
- 03/22/23
- Fed says 'additional policy firming may be appropriate'
|
